✦ LIBER ✦

Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer

✍ Scribed by Revati J. Tatake; Nirmala Krishnan; R. S. Rao; A. R. Fakih; Sudha G. Gangal

Publisher: John Wiley and Sons
Year: 1989
Tongue: French
Weight: 681 KB
Volume: 43
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.2910430405

No coin nor oath required. For personal study only.

✦ Synopsis

Publication of the International Union Against Cancer Publication de i'Union lnternationale Contre le Cancer

📜 SIMILAR VOLUMES

Lymphokine-activated killer cell functio

Lymphokine-activated killer cell function of lymphocytes from regional lymph nodes in patients with gastric carcinoma

✍ Shinya Arinaga; Nobuya Karimine; Shigeru Nanbara; Hiroshi Inoue; Hideaki Nakashi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

Lymphokine-activated killer (LAK) cells generated by culture of regional lymph node cells (LNC) with interleukin 2 (IL 2) for 4 and 11 days were examined for their functional capabilities in comparison with those of peripheral blood mononuclear cells (PBM) in 25 patients with gastric carcinoma. The

Lymphokine-activated killer cell activit

Lymphokine-activated killer cell activity of peripheral blood, spleen, regional lymph node, and tumor infiltrating lymphocytes in gastric cancer patients

✍ Nobuya Karimine; Shigeru Nanbara; Shinya Arinaga; Tsukasa Asoh; Hiroaki Ueo; Tsu 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 661 KB

Lymphokine-activated killer (LAK) cell activity of peripheral blood mononuclear cells (PBM), spleen cells (SPC), regional lymph node cells (LNC), and tumor-infiltrating lymphocytes (TIL), induced by activation with interleukin 2 (IL 2) for 4 days, was evaluated in patients with gastric carcinoma. TI

Functional characterization of tumor-inf

Functional characterization of tumor-infiltrating lymphocytes, lymph-node lymphocytes and peripheral-blood lymphocytes from patients with breast cancer

✍ Andrea Rubbert; Bernhard Manger; Norbert Lang; Joachim R. Kalden; Erich Platzer 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 924 KB

Mononuclear cell infiltration is frequently seen within human solid tumors. Effector cells within the tumor site usually fail to exhibit cytotoxic or natural killer activity when freshly isolated; however, they develop potent and sometimes specific cytotoxicity after expansion in ILL Thus, local tum

Different immune functions of peripheral

Different immune functions of peripheral blood, regional lymph node, and tumor infiltrating lymphocytes in lung cancer patients

✍ Hiroshige Nakamura; Kiyosuke Ishiguro; Tohru Mori 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 836 KB

Lack of correlation between peripheral b

Lack of correlation between peripheral blood lymphokine-activated killer (lak) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2

✍ A. K. Ghosh; H. Dazzi; N. Thatcher; M. Moore 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 634 KB

A phase-1/11 study of recombinant interleukin 2 (rll-2) was performed in 31 melanoma patients. The first dose of rlL-2 was given intrasplenically followed 4 hr later by an i.v. dose and 3 further i.v. doses on alternate days. Three courses of treatment were planned at 3-week intervals. The maximum t

Tumor-specific CD8+ T lymphocytes derive

Tumor-specific CD8+ T lymphocytes derived from the peripheral blood of prostate cancer patients by in vitro stimulation with autologous tumor cell lines

✍ Franck Housseau; Daniel A. Langer; Samuel D. Oberholtzer; Anitha Moorthy; Hyam I 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 150 KB 👁 2 views

## Abstract To identify tumor‐associated antigens as putative targets for developing immunotherapies against prostate cancer, we investigated the ability of T cells derived from the peripheral blood lymphocytes of prostate cancer patients to recognize autologous tumor cells. The technical challenge